2027 Process Development Rotation Program (2 years)

2027 Process Development Rotation Program (2 years) Department Summary This role is a valuable part of Pharmaceutical Technical Development (PTD), dedicated to advancing Genentech’s protein pharmaceutical pipeline from discovery to commercialization. As a member of this organization, you will have the opportunity to engage in innovative process development, formulation, and analytical method optimization while collaborating closely with multidisciplinary teams. Your contributions will be crucial in delivering novel medicines that meet the critical needs of patients. This position is based in South San Francisco, on site. The Opportunity Process Development Rotation Program (PDRP) offers associates the opportunity to experience four diverse six-month assignments over the course of two years within various areas of the process development organization (see more here). In this program, you will have the opportunity to: Experience working on meaningful projects: directly support a molecule, explore a complex scientific question, or evaluate and implement new technologies, supporting areas such as: cell culture development, purification development, analytical development & protein characterization, and drug product process development. Collaborate with cross-functional teams to optimize our current processes and technologies. Engage in hands-on lab work and rigorous data analysis. Actively participate in professional development committees within the PDRP organization. Build a cross-functional network across our process development group. Who You Are Required Education Recent graduates (less than two years from the program start date) with a B.S., B.A., or M.S. degree. Required Disciplines Chemical engineering, biochemical engineering, analytical chemistry, biochemistry, molecular biology, biomedical engineering, bioengineering, microbiology, biology, or related disciplines. Knowledge, Skills, and Qualifications Passionate about science and engineering, data-driven, and enjoy the challenges associated with complex problem-solving. Highly self-motivated and willing to work independently or as part of multi-disciplinary teams. Demonstrated leadership experience in academic, extracurricular, or professional settings (e.g., leading a club, team projects, or other initiatives). Strong critical thinking, verbal and written communication, and collaboration skills. Preferred Experience Experience working in research labs or industrial internships. Experience working with biologics (proteins, cells, mRNA, DNA) and related technical skills. Compensation The expected hourly rate for this position based on the primary location of California is $44.72. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. Benefits Benefits Notes: Relocation benefits are available for those that qualify. The position also qualifies for the benefits detailed at the link provided below. Company Culture The target start date for this position is August 2027. Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company’s policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants. Who We Are Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. #J-18808-Ljbffr F. Hoffmann-La Roche AG